• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液系统恶性肿瘤性感染性休克患者使用oXiris进行连续性肾脏替代治疗:一项回顾性研究。

Continuous renal replacement therapy with oXiris in patients with hematologically malignant septic shock: A retrospective study.

作者信息

Wang Juan, Wei Shu-Run, Ding Tong, Zhang Li-Ping, Weng Zhi-Hua, Cheng Ming, Zhou Yang, Zhang Meng, Liu Fang-Jun, Yan Bei-Bei, Wang Dan-Feng, Sun Ming-Wen, Cheng Wei-Xin

机构信息

Intensive Care Unit, Hebei Yanda Hospital, Langfang 065201, Hebei Province, China.

Department of Emergency, Peking University International Hospital, Beijing 102206, China.

出版信息

World J Clin Cases. 2023 Sep 16;11(26):6073-6082. doi: 10.12998/wjcc.v11.i26.6073.

DOI:10.12998/wjcc.v11.i26.6073
PMID:37731565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10507551/
Abstract

BACKGROUND

The mortality rate from septic shock in patients with hematological malignancies (HMs) remains significantly higher than that in patients without HMs. A longer resuscitation time would definitely be harmful because of the irreversibly immunocompromised status of the patients. Shortening the resuscitation time through continuous renal replacement therapy (CRRT) with oXiris would be an attractive strategy in managing such patients.

AIM

To explore the effects of CRRT and oXiris in shortening the resuscitation time and modifying the host response by reducing inflammation mediator levels.

METHODS

Forty-five patients with HM were diagnosed with septic shock and underwent CRRT between 2018 and 2022. Patients were divided into two groups based on the hemofilter used for CRRT (oXiris group, = 26; M150 group, = 19). We compared the number of days of negative and total fluid balance after 7 d of CRRT between the groups. The heart rate, norepinephrine dose, Sequential Organ Failure Assessment (SOFA) score, and blood lactic acid levels at different time points in the two groups were also compared. Blood levels of inflammatory mediators in the 26 patients in the oXiris group were measured to further infer the possible mechanism.

RESULTS

The average total fluid balance after 7 d of CRRT in the oXiris group was significantly lower than that of patients in the M150 hemofilter group. The SOFA scores of patients after CRRT with oXiris therapy were significantly lower than those before treatment on day 1 (d1), d3 and d7 after CRRT; these parameters were also significantly lower than those of the control group on d7. The lac level after oXiris therapy was significantly lower than that before treatment on d3 and d7 after CRRT. There were no significant differences in the above parameters between the two groups at the other time points. In the oXiris group, procalcitonin levels decreased on d7, whereas interleukin-6 and tumor necrosis factor levels decreased significantly on d3 and d7 after treatment.

CONCLUSION

CRRT with oXiris hemofilter may improve hemodynamics by reducing inflammatory mediators and playing a role in shortening the resuscitation period and decreasing total fluid balance in the resuscitation phases.

摘要

背景

血液系统恶性肿瘤(HM)患者感染性休克的死亡率仍显著高于非HM患者。由于患者存在不可逆的免疫功能低下状态,较长的复苏时间肯定有害。通过使用oXiris进行连续性肾脏替代治疗(CRRT)来缩短复苏时间,可能是治疗这类患者的一个有吸引力的策略。

目的

探讨CRRT及oXiris在缩短复苏时间及通过降低炎症介质水平改变宿主反应方面的作用。

方法

45例HM患者被诊断为感染性休克,并于2018年至2022年期间接受CRRT治疗。根据用于CRRT的血液滤过器将患者分为两组(oXiris组,n = 26;M150组,n = 19)。我们比较了两组CRRT 7天后的负平衡天数和总液体平衡。还比较了两组不同时间点的心率、去甲肾上腺素剂量、序贯器官衰竭评估(SOFA)评分和血乳酸水平。检测oXiris组26例患者血液中炎症介质水平,以进一步推断可能的机制。

结果

oXiris组CRRT 7天后的平均总液体平衡显著低于M150血液滤过器组患者。接受oXiris治疗的患者CRRT后的SOFA评分在CRRT后第1天(d1)、d3和d7显著低于治疗前;这些参数在d7时也显著低于对照组。oXiris治疗后d3和d7的乳酸水平显著低于治疗前。两组在其他时间点上述参数无显著差异。在oXiris组,降钙素原水平在d7时下降,而白细胞介素-6和肿瘤坏死因子水平在治疗后d3和d7时显著下降。

结论

使用oXiris血液滤过器的CRRT可能通过减少炎症介质来改善血流动力学,在缩短复苏期和减少复苏阶段的总液体平衡方面发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ec/10507551/58789166fa6e/WJCC-11-6073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ec/10507551/6fa1e7074498/WJCC-11-6073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ec/10507551/9e89653ce838/WJCC-11-6073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ec/10507551/58789166fa6e/WJCC-11-6073-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ec/10507551/6fa1e7074498/WJCC-11-6073-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ec/10507551/9e89653ce838/WJCC-11-6073-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ec/10507551/58789166fa6e/WJCC-11-6073-g003.jpg

相似文献

1
Continuous renal replacement therapy with oXiris in patients with hematologically malignant septic shock: A retrospective study.血液系统恶性肿瘤性感染性休克患者使用oXiris进行连续性肾脏替代治疗:一项回顾性研究。
World J Clin Cases. 2023 Sep 16;11(26):6073-6082. doi: 10.12998/wjcc.v11.i26.6073.
2
Application of Different Continuous Renal Replacement Therapy Hemofilter in Patients with Septic Shock Complicated with Acute Renal Injury.不同连续性肾脏替代治疗血液滤过器在脓毒症休克合并急性肾损伤患者中的应用
Iran J Public Health. 2022 Oct;51(10):2317-2324. doi: 10.18502/ijph.v51i10.10990.
3
Continuous Renal Replacement Therapy With Adsorbing Filter oXiris in Acute Kidney Injury With Septic Shock: A Retrospective Observational Study.使用吸附滤器oXiris进行连续性肾脏替代治疗在脓毒性休克合并急性肾损伤中的应用:一项回顾性观察研究
Front Med (Lausanne). 2022 Apr 8;9:789623. doi: 10.3389/fmed.2022.789623. eCollection 2022.
4
Successful treatment of gastrointestinal infection-induced septic shock using the oXiris hemofilter: A case report.使用oXiris血液滤过器成功治疗胃肠道感染引起的感染性休克:一例报告。
World J Clin Cases. 2021 Sep 26;9(27):8157-8163. doi: 10.12998/wjcc.v9.i27.8157.
5
COMPARISON OF OXIRIS AND CONVENTIONAL CONTINUOUS RENAL REPLACEMENT THERAPY IN MANAGING SEVERE ABDOMINAL INFECTIONS: IMPACT ON SEPTIC SHOCK MORTALITY.Oxiris与传统连续性肾脏替代疗法在治疗严重腹部感染中的比较:对感染性休克死亡率的影响
Shock. 2024 Oct 1;62(4):529-538. doi: 10.1097/SHK.0000000000002437. Epub 2024 Aug 14.
6
[Usage of oXiris hemofilter for septic shock patients: a single-center experience].[oXiris血液滤过器在感染性休克患者中的应用:单中心经验]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Dec;31(12):1531-1534. doi: 10.3760/cma.j.issn.2095-4352.2019.12.019.
7
Extracorporeal blood purification with Oxiris filter in critically ill patients with COVID-19 requiring continuous renal replacement therapy.COVID-19 危重症患者行连续性肾脏替代治疗时使用 Oxiris 滤器进行体外血液净化。
Int J Artif Organs. 2023 Dec;46(12):629-635. doi: 10.1177/03913988231207716. Epub 2023 Nov 5.
8
Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study.奥昔里斯膜对感染性休克患者内毒素和细胞因子的清除作用:一项随机交叉双盲研究。
PLoS One. 2019 Aug 1;14(8):e0220444. doi: 10.1371/journal.pone.0220444. eCollection 2019.
9
Early use of endotoxin absorption by oXiris in abdominal septic shock: A case report.oXiris内毒素吸附在腹部感染性休克中的早期应用:一例报告
Medicine (Baltimore). 2020 Jul 10;99(28):e19632. doi: 10.1097/MD.0000000000019632.
10
Clinical efficacy of oXiris-continuous hemofiltration adsorption in septic shock patients: A retrospective analysis.oXiris连续性血液滤过吸附对感染性休克患者的临床疗效:一项回顾性分析。
Med Intensiva (Engl Ed). 2025 Mar;49(3):135-144. doi: 10.1016/j.medine.2024.09.012. Epub 2024 Oct 10.

引用本文的文献

1
Continuous renal replacement therapy with adsorbing filter oXiris in the treatment of sepsis associated acute kidney injury: a single-center retrospective observational study.采用吸附滤器oXiris进行持续肾脏替代治疗脓毒症相关性急性肾损伤:一项单中心回顾性观察研究
BMC Nephrol. 2024 Dec 18;25(1):456. doi: 10.1186/s12882-024-03897-0.
2
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.脓毒性休克的挑战:从新的血流动力学到血液净化疗法
J Pers Med. 2024 Feb 3;14(2):176. doi: 10.3390/jpm14020176.

本文引用的文献

1
Risk Factors and Outcomes in Critically Ill Patients with Hematological Malignancies Complicated by Hospital-Acquired Infections.危重症血液病合并医院获得性感染患者的危险因素和结局。
Medicina (Kaunas). 2023 Jan 22;59(2):214. doi: 10.3390/medicina59020214.
2
The End of "One Size Fits All" Sepsis Therapies: Toward an Individualized Approach.“一刀切”式脓毒症治疗的终结:迈向个体化治疗方法
Biomedicines. 2022 Sep 12;10(9):2260. doi: 10.3390/biomedicines10092260.
3
Outcomes and Predictors of 28-Day Mortality in Patients With Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria.
根据脓毒症-3标准定义的血液系统恶性肿瘤合并感染性休克患者28天死亡率的结局及预测因素
J Natl Compr Canc Netw. 2022 Jan;20(1):45-53. doi: 10.6004/jnccn.2021.7046.
4
Evaluation of the Oxiris Membrane in Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation Support: Study Protocol for a Single Center, Single-Blind, Randomized Controlled Trial.评估用于需要体外膜肺氧合支持的心源性休克的Oxiris膜:一项单中心、单盲、随机对照试验的研究方案。
Front Cardiovasc Med. 2021 Oct 11;8:738496. doi: 10.3389/fcvm.2021.738496. eCollection 2021.
5
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.拯救脓毒症运动:2021年脓毒症和脓毒性休克国际管理指南
Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2.
6
The Potential Role of Extracorporeal Cytokine Removal in Hemodynamic Stabilization in Hyperinflammatory Shock.体外细胞因子清除在高炎症性休克血流动力学稳定中的潜在作用
Biomedicines. 2021 Jul 1;9(7):768. doi: 10.3390/biomedicines9070768.
7
The application value of oXiris-endotoxin adsorption in sepsis.oXiris内毒素吸附在脓毒症中的应用价值
Am J Transl Res. 2021 Apr 15;13(4):3839-3844. eCollection 2021.
8
Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris) Hemofilter as a Treatment Modality for COVID-19 Patients: a Single-Centre Case Series.早期使用 AN69ST(oXiris)血液滤过器进行体外血液净化作为 COVID-19 患者的治疗方法:一项单中心病例系列研究。
Braz J Cardiovasc Surg. 2022 Mar 10;37(1):35-47. doi: 10.21470/1678-9741-2020-0403.
9
Early use of endotoxin absorption by oXiris in abdominal septic shock: A case report.oXiris内毒素吸附在腹部感染性休克中的早期应用:一例报告
Medicine (Baltimore). 2020 Jul 10;99(28):e19632. doi: 10.1097/MD.0000000000019632.
10
The haemodynamic effects of oXiris haemofilter in septic shock patients requiring renal support: A single-centre experience.oXiris血液滤过器对需要肾脏支持的感染性休克患者的血流动力学影响:一项单中心经验。
Int J Artif Organs. 2021 Jan;44(1):17-24. doi: 10.1177/0391398820917150. Epub 2020 May 11.